Skip to main content
Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawal.
Are the high-costs of MS disease-modifying therapies justified?
The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults.
Examining the contributions of environmental quality to pediatric multiple sclerosis.
The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies.